No abstract available.
Vaccination*

No abstract available.
Vaccination*

No abstract available.
Vaccination*

No abstract available.
Vaccination*

Background: To determine the level of knowledge, attitude and compliance of employees in St. Paul’s Hospital in Iloilo City to the 2012 Recommended Immunization for Filipino Healthcare Workers Methodology: This was a cross-sectional study participated in by 261 employees. An expert-validated research instrument was used during the survey with simple random sampling as a method in selecting study participants. Socio-demographic profile, health status, awareness of the 2012 Recommended Immunization for Healthcare Workers, their knowledge, attitude, and compliance to it, and the reasons why they received or refused vaccination were described. Descriptive statistics were utilized for data analysis. Results: Nine out of ten study participants were either moderately knowledgeable (51.3%) or highly knowledgeable (35.2%) on the said immunization schedule. As to attitude, seven out of ten study participants (74.7%) have favorable attitude while the remaining 25% have either ambivalent (24.1%) or unfavorable (1.2%) attitude. With regard to compliance, nine out of ten study participants either have better (85.82%) or excellent (10.48%) level of compliance and about 4% (3.7%) have poor level of compliance. The top three reasons for having vaccination are: “It protects my health” (85.4%), “It is safe” (81.6%), and “It is effective” (76.5%). The study participants’ top three reasons for not receiving vaccination are: “It is expensive” (78%), “I’m busy” (41.9%), and “I forgot” (32.3%). Conclusion Study participants’ level of awareness, knowledge, attitude, and compliance to 2012 Recommended Immunization for Healthcare Workers were far from the optimum level. Most were aware of the guidelines, moderately knowledgeable and complied to it in general. Why they either complied or refused to follow the guidelines appeared to be personal in nature.
Vaccination

Introduction: Hepatitis B virus (HBV) infection is one of the major public health problems in Malaysia. It remains the most common permanent deferral among blood donors. In Malaysia, the national vaccination programme has been introduced since 1989 to prevent HBV transmission. The objective of this study is to determine the prevalence and associated risk factors of HBV infection among first-time blood donors after the implementation of the national hepatitis B vaccination programme. Methods: This is a retrospective cohort study involving tracing of the database of National Blood Centre Malaysia. The record of first-time blood donors who had donated between 1st January 2010 and 31st December 2015 and were screened HBV positive was reviewed and analysed. Results: There were 376,737 first-time donors who had donated blood and 575 of them screened positive for HBV. The overall prevalence of seropositive for hepatitis B was 0.15%. The prevalence was higher at 0.23% among donors born before the year 1989 (pre-vaccination era) compared to 0.05% among donors born in and after the year 1989 (post-vaccination era). Perinatal transmission was found to have 15 times higher odds of developing HBV infection as compared to those who had the combination of risk factors among those born after the year 1989 (adjusted OR=14.95, 95% CI 1.80=124.01). Conclusion: The implementation of the national vaccination programme reduced the prevalence of hepatitis B among donors who received vaccination at birth compared to those who did not.
Vaccination

No abstract available.
Pilomatrixoma* ; Vaccination*

No abstract available.
Korea* ; Vaccination*

Persistence of antibody against hepatitis A virus has been studied in 30 healthy adults at 24th month after receiving a three doses schedule of hepatitis A vaccine (Havax). Results: Residual level in all subjects was higher than protective level (≥ 20mIU/ml). The GMT was higher than the protective level (831,5mIU/ml) 40 times and 100% people injected remained protective antibody.
Hepatitis A ; Vaccination

No abstract available.
Pilomatrixoma* ; Vaccination*